Robert Neville
2019
In 2019, Robert Neville earned a total compensation of $1M as Chief Executive Officer at Mast Therapeutics, a 75% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $238,875 |
|---|---|
| Option Awards | $240,941 |
| Salary | $546,000 |
| Other | $22,000 |
| Total | $1,047,816 |
Neville received $546K in salary, accounting for 52% of the total pay in 2019.
Neville also received $238.9K in non-equity incentive plan, $240.9K in option awards and $22K in other compensation.
Rankings
In 2019, Robert Neville's compensation ranked 9,076th out of 13,971 executives tracked by ExecPay. In other words, Neville earned more than 35.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,076 out of 13,971 | 35th |
Division Manufacturing | 3,639 out of 5,695 | 36th |
Major group Chemicals And Allied Products | 1,374 out of 2,194 | 37th |
Industry group Drugs | 1,171 out of 1,880 | 38th |
Industry Pharmaceutical Preparations | 866 out of 1,392 | 38th |
Source: SEC filing on April 15, 2020.
Neville's colleagues
We found two more compensation records of executives who worked with Robert Neville at Mast Therapeutics in 2019.